Evidence map›Paper›PMID 20147892›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2010

Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.

Riju Ray, Nandita Mitra, Don Baldwin, Mengye Guo, Freda Patterson, Daniel F Heitjan, Christopher Jepson, E Paul Wileyto, Jinxue Wei, Thomas Payne and 3 more

Registry-linked trialOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00364156 (Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation), which is not on this map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00364156 phase3completednot on this map

Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation

TypeinterventionalSponsorUniversity of PennsylvaniaRan2004 to 2008Enrolled568ConditionsTOBACCO USE CESSATIONArmsStandard Patch Treatment, 24-weeks of nicotine patch
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2011
    Pooled it
  4. Trial
  5. Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Trial
  6. Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Trial
  7. Article
  8. Review
  9. Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Translational research in nicotine dependence.Cold Spring Harbor perspectives in medicine · 2013
    Review
  17. Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2012
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Riju RayDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Nandita Mitra
Don Baldwin
Mengye Guo
Freda Patterson
Daniel F Heitjan
Christopher Jepson
E Paul Wileyto
Jinxue Wei
Thomas Payne
Jennie Z Ma
Ming D Li
Caryn Lerman
University of Pennsylvania · USUniversity of Virginia · USUniversity of Mississippi Medical Center · US

Funding

University of Toronto Coordinating Genetics Core & Clinical Trial SiteU01DA020830 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CONTI, DAVID V · 2005 to 2014
$22.4M
TRANSDISCIPLINARY TOBACCO USE RESEARCH CENTERSP50CA084718 · NCI · UNIVERSITY OF PENNSYLVANIA · PI PERKINS, KENNETH ALAN · 1999 to 2008
$17.8M
MAPPING OF SUSCEPTIBILITY LOCI FOR NICOTINE DEPENDENCER01DA012844 · NIDA · UNIVERSITY OF VIRGINIA · PI LI, MING D · 1999 to 2013
$10.0M
Neuroimaging Abstinence and Medication ResponseP50CA143187 · NCI · UNIVERSITY OF PENNSYLVANIA · PI AUDRAIN-MCGOVERN, JANET E · 2009 to 2013
$8.6M
NCI NIH HHS P50 CA143187NCI NIH HHS P50 CA/DA84718NIDA NIH HHS DA012844NIDA NIH HHS R01 DA012844NIDA NIH HHS U01 DA020830
6 · The paper itself

Abstract

The ability to quit smoking is heritable, yet few genetic studies have investigated prospective smoking cessation. We conducted a systems-based genetic association analysis in a sample of 472 treatment-seeking smokers of European ancestry after 8 weeks of transdermal nicotine therapy for smoking cessation. The genotyping panel included 169 single-nucleotide polymorphisms (SNPs) in 7 nicotinic acetylcholine receptor subunit genes and 4 genes in the endogenous cholinergic system. The primary outcome was smoking cessation (biochemically confirmed) at the end of treatment. SNPs clustered in the choline acetyltransferase (ChAT) gene were individually identified as nominally significant, and a 5-SNP haplotype (block 6) in ChAT was found to be significantly associated with quitting success. Single SNPs in ChAT haplotype block 2 were also associated with pretreatment levels of nicotine dependence in this cohort. To replicate associations of SNPs in haplotype blocks 2 and 6 of ChAT with nicotine dependence in a non-treatment-seeking cohort, we used data from an independent community-based sample of 629 smokers representing 200 families of European ancestry. Significant SNP and haplotype associations were identified for multiple measures of nicotine dependence. Although the effect sizes in both cohorts are modest, converging data across cohorts and phenotypes suggest that ChAT may be involved in nicotine dependence and ability to quit smoking. Additional sequencing and characterization of ChAT may reveal functional variants that contribute to nicotine dependence and smoking cessation.

Indexed as

AcetylcholineAdultBrain ChemistryCholine O-AcetyltransferaseCohort StudiesFemaleGene Expression Regulation, EnzymologicGenetic MarkersGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotideProtein SubunitsAcetylcholineCholine O-AcetyltransferaseGenetic MarkersProtein SubunitsReceptors, Nicotinic

Identifiers

PMID20147892
PMCPMC2855736
OpenAlexW1966290863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.